Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases

被引:0
|
作者
Morten L Halling [1 ]
Jens Kjeldsen [2 ]
Torben Knudsen [1 ]
Jan Nielsen [3 ]
Lars Koch Hansen [2 ]
机构
[1] Department of Gast-roenterology and Hepatology,Hospital of Southwest Jutland
[2] Department of Medical Gastroenterology S,Odense University Hospital
[3] Center for Clinical Epidemiology,Odense Uni-versity Hospital
关键词
Immune mediated diseases; Ulcerative colitis; Risk; Prevalence; Registry; Chronic inflammatory diseases; Autoimmune diseases; Inflammatory bowel disease; Crohn’s disease; extraintestinal manifestations;
D O I
暂无
中图分类号
R574 [肠疾病]; R593.2 [自身免疫性疾病、结缔组织疾病];
学科分类号
1002 ; 100201 ;
摘要
AIM To investigate whether immune mediated diseases(IMD) are more frequent in patients with inflammatory bowel disease(IBD).METHODS In this population based registry study,a total of 47325 patients with IBD were alive and registered in the Danish National Patient Registry on December 16,2013. Controls were randomly selected from the Danish Civil Registration System(CRS) and matched for sex,age,and municipality. We used ICD 10 codes to identify the diagnoses of the included patients. The IBD population was divided into three subgroups: Ulcerative colitis(UC),Crohn’s disease(CD) and Both the latter referring to those registered with both diagnoses. Subsequently,odds-ratios(OR) and 95%CI were obtained separately for each group and their respective controls. The use of Bonferoni post-test correction adjusted the significance level to P < 0.00125. P-values were estimated using Fisher’s exact test.RESULTS There were significantly more women than men in the registry,and a greater percentage of comorbidity in the IBD groups(P < 0.05). Twenty different IMDs were all significantly more frequent in the IBD group. Sixteen were associated with UC versus twelve with CD. In both UC and CD ORs were significantly increased(P < 0.00125) for primary sclerosing cholangitis(PSC),celiac disease,type 1 diabetes(T1D),sarcoidosis,asthma,iridocyclitis,psoriasis,pyoderma gangrenosum,rheumatoid arthritis,and ankylosing spondylitis. Restricted to UC(P < 0.00125) were autoimmune hepatitis,primary biliary cholangitis,Grave’s disease,polymyalgia rheumatica,temporal arteritis,and atrophic gastritis. Restricted to CD(P < 0.00125) were psoriatic arthritis and episcleritis. Restricted to women with UC(P < 0.00125) were atrophic gastritis,rheumatoid arthritis,temporal arteritis,and polymyalgia rheumatica. Restricted to women with CD were episcleritis,rheumatoid arthritis,and psoriatic arthritis. The only disease restricted to men(P < 0.00125) was sarcoidosis. CONCLUSION Immune mediated diseases were significantly more frequent in patients with IBD. Our results strengthen the hypothesis that some IMDs and IBD may have overlapping pathogenic pathways.
引用
收藏
页码:6137 / 6146
页数:10
相关论文
共 50 条
  • [41] Autoimmune Pancreatitis in Patients with chronic inflammatory Bowel Disease
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (04):
  • [42] Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases
    Rocha, Henrique C.
    Vilela, Eduardo G.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (02): : 83 - 90
  • [43] Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases
    Schneeweiss, Maria C.
    Kirchgesner, Julien
    Wyss, Richard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB86 - AB86
  • [44] INFLAMMATORY BOWEL DISEASE PATIENTS HAVE AN INCREASED RISK OF MALNUTRITION AND SARCOPENIA COMPARED TO PATIENTS SEEKING GENERAL GASTROENTEROLOGY CARE
    Gold, Stephanie L.
    Philippou, Alicia
    Kohler, David
    Rabinowitz, Loren
    Manning, Laura
    Bergstein, Suzannah
    Birhanu, Beselot
    Keefer, Laurie
    Dubinsky, Marla C.
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2022, 162 (07) : S656 - S656
  • [45] Inflammatory bowel disease is not associated with an increased risk of lymphoma
    Lewis, JD
    Bilker, WB
    Brensinger, C
    Deren, JJ
    Vaughn, DJ
    Strom, BL
    GASTROENTEROLOGY, 2001, 121 (05) : 1080 - 1087
  • [46] Airway involvement in inflammatory bowel disease: Inflammatory bowel disease patients have bronchial wall thickening
    Majima, Suguru
    Wakahara, Keiko
    Iwano, Shingo
    Kinoshita, Fumie
    Nakamura, Masanao
    Hashimoto, Naozumi
    Fujishiro, Mitsuhiro
    Hasegawa, Yoshinori
    RESPIRATORY INVESTIGATION, 2022, 60 (05) : 713 - 719
  • [47] Comparative analysis of chronic kidney disease risk: Inflammatory bowel disease vs. autoimmune diseases
    Chuang, Ming-Che
    Lin, Cheng-Li
    Tsai, Fuu-Jen
    Tsai, Tsung-Yu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 155 - 156
  • [48] Immunomodulator and biological therapy are increased in inflammatory bowel disease patients with associated immune-mediated inflammatory diseases
    Garcia Garcia, M. J.
    Pascual Mato, M.
    Del Pozo Calzada, C.
    Rasines Perez, L.
    Castro Senosiain, B.
    Crespo Garcia, J.
    Rivero Tirado, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S245 - S246
  • [49] PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE A SIGNIFICANTLY HIGHER RISK OF CEREBROVASCULAR ACCIDENTS
    Ghoneim, Sara
    Shah, Aun
    Dhore, Aneesh
    Butt, Muhammad U.
    Ali, Rubab
    Waghray, Nisheet
    GASTROENTEROLOGY, 2020, 158 (06) : S935 - S936
  • [50] Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases
    Samadder, N. Jewel
    Valentine, John F.
    Guthery, Stephen
    Singh, Harminder
    Bernstein, Charles N.
    Leighton, Jonathan A.
    Wan, Yuan
    Wong, Jathine
    Boucher, Kenneth
    Pappas, Lisa
    Rowe, Kerry
    Burt, Randall W.
    Curtin, Karen
    Smith, Ken R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1807 - +